146 related articles for article (PubMed ID: 12084521)
21. Hemorphin and hemorphin-like peptides isolated from dog pancreas and sheep brain are able to potentiate bradykinin activity in vivo.
Ianzer D; Konno K; Xavier CH; Stöcklin R; Santos RA; de Camargo AC; Pimenta DC
Peptides; 2006 Nov; 27(11):2957-66. PubMed ID: 16904236
[TBL] [Abstract][Full Text] [Related]
22. Quantification of hemorphins in Alzheimer's disease brains.
Poljak A; McLean CA; Sachdev P; Brodaty H; Smythe GA
J Neurosci Res; 2004 Mar; 75(5):704-14. PubMed ID: 14991846
[TBL] [Abstract][Full Text] [Related]
23. Molecular insights into the interaction of hemorphin and its targets.
Ali A; Baby B; Soman SS; Vijayan R
Sci Rep; 2019 Oct; 9(1):14747. PubMed ID: 31611567
[TBL] [Abstract][Full Text] [Related]
24. Hemorphins inhibit angiotensin IV binding and interact with aminopeptidase N.
Garreau I; Chansel D; Vandermeersch S; Fruitier I; Piot JM; Ardaillou R
Peptides; 1998; 19(8):1339-48. PubMed ID: 9809647
[TBL] [Abstract][Full Text] [Related]
25. Structural requirements and mechanism of the pressor activity of Leu-Val-Val-hemorphin-7, a fragment of hemoglobin beta-chain in rats.
Moisan S; Harvey N; Beaudry G; Forzani P; Burhop KE; Drapeau G; Rioux F
Peptides; 1998; 19(1):119-31. PubMed ID: 9437744
[TBL] [Abstract][Full Text] [Related]
26. A globin fragment, LVV-hemorphin-7, induces [3H]thymidine incorporation in a neuronal cell line via the AT4 receptor.
Moeller I; Albiston AL; Lew RA; Mendelsohn FA; Chai SY
J Neurochem; 1999 Jul; 73(1):301-8. PubMed ID: 10386983
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of intraerythrocytic proteasome retards the generation of hemorphins.
Song CZ; Wang QW; Liu H; Song CC
Peptides; 2012 Jan; 33(1):170-3. PubMed ID: 22154669
[TBL] [Abstract][Full Text] [Related]
28. Isolation of new ligands for orphan receptor MRGPRX1-hemorphins LVV-H7 and VV-H7.
Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
Peptides; 2017 Oct; 96():61-66. PubMed ID: 28867075
[TBL] [Abstract][Full Text] [Related]
29. Interaction of new VV-hemorphin-5 analogues with cell membrane models.
Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
Colloids Surf B Biointerfaces; 2022 Dec; 220():112896. PubMed ID: 36270140
[TBL] [Abstract][Full Text] [Related]
30. Hemorphin peptides are released from hemoglobin by cathepsin D. radioimmunoassay against the C-part of V-V-hemorphin-7: an alternative assay for the cathepsin D activity.
Garreau I; Cucumel K; Dagouassat N; Zhao Q; Cupo A; Piot JM
Peptides; 1997; 18(2):293-300. PubMed ID: 9149303
[TBL] [Abstract][Full Text] [Related]
31. Brain processing of hemorphin-7 peptides in various subcellular fractions from rats.
Murillo L; Piot JM; Coitoux C; Fruitier-Arnaudin I
Peptides; 2006 Dec; 27(12):3331-40. PubMed ID: 17097762
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch.
Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A
Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096
[TBL] [Abstract][Full Text] [Related]
33. Hemorphins act as homeostatic agents in response to endotoxin-induced stress.
Barkhudaryan N; Zakaryan H; Sarukhanyan F; Gabrielyan A; Dosch D; Kellermann J; Lottspeich F
Neurochem Res; 2010 Jun; 35(6):925-33. PubMed ID: 19967445
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
[TBL] [Abstract][Full Text] [Related]
35. Radioligand binding properties of VV-hemorphin 7, an atypical opioid peptide.
Szikra J; Benyhe S; Orosz G; Darula Z; Piot JM; Fruitier I; Monory K; Hanoune J; Borsodi A
Biochem Biophys Res Commun; 2001 Mar; 281(3):670-7. PubMed ID: 11237710
[TBL] [Abstract][Full Text] [Related]
36. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate.
Zhao Q; Sannier F; Garreau I; Guillochon D; Piot JM
Biochem Biophys Res Commun; 1994 Oct; 204(1):216-23. PubMed ID: 7945362
[TBL] [Abstract][Full Text] [Related]
37. LVV-hemorphin-4 modulates Ca2+/calmodulin-dependent pathways in the immune system by the same mechanism as in the brain.
Barkhudaryan N; Gambarov S; Gyulbayazyan T; Nahapetyan K
J Mol Neurosci; 2002 Jun; 18(3):203-10. PubMed ID: 12059038
[TBL] [Abstract][Full Text] [Related]
38. Positive Modulation of Angiotensin II Type 1 Receptor-Mediated Signaling by LVV-Hemorphin-7.
Ali A; Palakkott A; Ashraf A; Al Zamel I; Baby B; Vijayan R; Ayoub MA
Front Pharmacol; 2019; 10():1258. PubMed ID: 31708782
[TBL] [Abstract][Full Text] [Related]
39. LVV-hemorphin 7 and angiotensin IV in correlation with antinociception and anti-thermal hyperalgesia in rats.
Cheng BC; Tao PL; Cheng YY; Huang EY
Peptides; 2012 Jul; 36(1):9-16. PubMed ID: 22484286
[TBL] [Abstract][Full Text] [Related]
40. Modulation of peripheral inflammation by locally administered hemorphin-7.
Sanderson K; Nyberg F; Khalil Z
Inflamm Res; 1998 Feb; 47(2):49-55. PubMed ID: 9535541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
